Table of Contents
What does Axsome therapeutics do?
The stock price of Axsome Therapeutics (NASDAQ: AXSM), a biopharmaceutical company focused on developing novel therapies for central nervous system conditions, has seen a 13\% rise over the last twenty-one trading sessions.
When will Axsome Therapeutics get FDA approval?
O>::AXSOME THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR AXS-07 FOR THE ACUTE TREATMENT OF MIGRAINE. AXSOME THERAPEUTICS INC – FDA HAS SET A PDUFA TARGET ACTION DATE OF APRIL 30, 2022 FOR NDA.
Is Axsm a good stock to buy?
Out of 7 analysts, 4 (57.14\%) are recommending AXSM as a Strong Buy, 2 (28.57\%) are recommending AXSM as a Buy, 1 (14.29\%) are recommending AXSM as a Hold, 0 (0\%) are recommending AXSM as a Sell, and 0 (0\%) are recommending AXSM as a Strong Sell. What is AXSM’s earnings growth forecast for 2021-2023?
Where is Axsome located?
Axsome Therapeutics is headquartered in New York, NY and has 2 office locations across 1 country.
Is Axsome Therapeutics black owned?
Publicly-Traded Black-Owned Company Stocks Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States.
Why is Axsome stock dropping?
So what. This nearly double-digit drop in Axsome’s share price could turn out to be a gift for investors. The biotech’s shares are currently well off of their 52-week highs due to a regulatory delay for its experimental major depressive disorder drug AXS-05.
Will AXS-05 get approved?
AXS-05 is not approved by the FDA. About Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options.
Is Axsome Therapeutics a good buy?
Axsome Therapeutics has received a consensus rating of Buy. The company’s average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.
When will Axsm stock go up?
During the day the stock fluctuated 6.05\% from a day low at $31.49 to a day high of $33.39….Predicted Opening Price for Axsome Therapeutics of Monday, December 6, 2021.
| Fair opening price December 6, 2021 | Current price |
|---|---|
| $32.37 | $32.24 (Undervalued) |
Is AMS a black-owned company?
American Shared Hospital Services (AMS) is a healthcare company that leases medical equipment to hospitals. It’s based in San Francisco and makes equipment for things like radiosurgery. The company was founded by Dr. But the company is still Black-owned, with his son as an executive.
Is Ping Black-Owned?
Publicly-Traded Black-Owned Company Stocks Ping Identity Holding Corp. provides intelligent identity solutions for the enterprise in the United States and internationally.
When is AXS-05 FDA approval?
AXS-05 for MDD, commercial launch, if approved. AXS-07 for acute migraine, commercial launch, if approved (2022)